Nicholson Garry A 4
4 · G1 Therapeutics, Inc. · Filed Jun 14, 2024
Insider Transaction Report
Form 4
Nicholson Garry A
Director
Transactions
- Award
Common Stock
2024-06-13+10,000→ 34,389 total - Award
Stock Options (Right to Buy)
2024-06-13+30,000→ 30,000 totalExercise: $2.99Exp: 2034-06-13→ Common Stock (30,000 underlying)
Footnotes (4)
- [F1]Represents a restricted stock unit ("RSU") award that vests in its entirety twelve months after June 13, 2024, subject to the Reporting Person's continued service as a director. The Reporting Person has elected to defer vesting of these shares pursuant to the G1 Therapeutics, Inc. Deferred Compensation Plan for Non-Employee Directors. The RSUs will vest upon termination of the Reporting Person's service as a Director on the Company's Board.
- [F2]Each RSU represents a contingent right to receive one share of Issuer common stock.
- [F3]Represents (i) 14,389 shares of common stock; (ii) 10,000 RSUs from award granted on June 15, 2023; and (iii) 10,000 RSUs from award granted on June 13, 2024.
- [F4]The shares underlying this option will vest in their entirety twelve months after June 13, 2024, subject to the Reporting Person's continued service as a director.